Share Name Share Symbol Market Type Share ISIN Share Description
Indivior LSE:INDV London Ordinary Share GB00BRS65X63 ORD USD0.10
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.20p -0.53% 411.30p 411.20p 411.40p 413.80p 404.50p 413.80p 192,917 09:57:58
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 688.2 193.4 21.7 18.0 2,965.43

Indivior Share Discussion Threads

Showing 376 to 396 of 400 messages
Chat Pages: 16  15  14  13  12  11  10  9  8  7  6  5  Older
DateSubjectAuthorDiscuss
22/1/2018
11:05
Ah ,its all about an announcement dated 21 January from Camarus, the Swedish rival which says it has received a Complete Response letter from the FDA on its proposed inject able product. Effectively delays this competitive launch for a good six months as I understand it. Good for the launch of the Indivior product this quarter.
gregmorg
11/1/2018
22:16
I find twas an even more interesting event on the 2nd January but no publicity at all on it- that is so far!!
gregmorg
03/1/2018
11:15
Interesting strategic link up with Swiss bio pharma. Indivior points to possible large milestone payments over time but as Phase 1 will only be some time this year that's still a lifetime away. Nevertheless, good to see link up with an impressive scientific partner.
gregmorg
03/1/2018
10:23
Um Fever Tree,looked at it as the price approached £8 and considered it a real gamble and the company would get swamped in a well timed Schweppes competitive response.It never happened.I have a friend who bought some and I fear that my lack of enthusiasm encouraged him to bank profits way too early!Happy New Year again,Greg
steeplejack
02/1/2018
20:41
Hi Steeplejack, Many thanks .A happy and prosperous New Year to you too. I will certainly look at the other stock. I am very bullish on this stock for the year. But-- whatever my optimism for later I am a little unsure as to what January even maybe early Feb will bring! January is usually slow off the mark and the professionals often do not get their act together till after the second week of the month, using strategy meetings, ascertaining where the loos are etc. etc. This time we have MIFID ,starting tomorrow, and the general consensus /feeling is volumes will be seriously impacted while the Regulations are absorbed /implemented and that could last for at least a few weeks. I associate low volumes with weak markets. Just an observation and a note of caution to myself rather than anything else. Very much hope the BUP Monthly blasts off, the US Govt litigation draws to a close, and the long awaited US listing. actually happens The odd relative had Fever Tree but not me --but for how long he has held wasn't actually disclosed, yet they teased me a tad over the festive period. Mind you, I should never have missed Charlie Wilson with Booker. His record with Stuart Rose spoke for itself. Anyway even to get a few decent ones now and again is OK by me. Wishing you well for the year ahead.
gregmorg
01/1/2018
11:38
Happy New Year Greg.Indivior provided a rocky but very profitable ride in 2017 and looks pretty well set for 2018.My best UK investment(albeit it has a Nasdaq listing too)was HCM,Hutchison China Meditech.Worth a look if you don't hold already.
steeplejack
20/12/2017
14:28
Indivior has entered into an amendment with various lenders to provide replacement term loan facilities in an aggregate principal amount of approximately $484m, it announced on Tuesday, replacing all of its dollar and euro-denominated term loans outstanding under the existing credit agreement. The FTSE 250 company sadi the new term loan facilities reduced the group's interest coupon to LIBOR plus 4.50%, from LIBOR plus 6.00%.
steeplejack
12/12/2017
10:47
Another good announcement this time on RBP-7000 NDA. Have to pencil in 28 July 2018 for the PDUFA! Hopefully next year will see this stock more recognized
gregmorg
02/12/2017
11:15
Http://www.thisismoney.co.uk/money/markets/article-5138849/Drug-approval-shot-arm-pharmaceutical-firm.html
the grumpy old men
01/12/2017
08:58
Ah, the PDUFA announcement came as expected this morning. Good news. Don't think there was much doubt it would be positive based on previous indicators although always an element in these things. We can relax a bit. Be interesting to see developments from here.
gregmorg
08/11/2017
09:43
Citibank upped its recommendation apparently. Maybe caught a few on the hop.
gregmorg
04/11/2017
16:59
I've only just taken a small holding here, it was going to be a day trade flip but upon looking at the near and long term horizon I have decided to give this the time for growth that it deserves. Smack is huge in Murca!
cmackay
03/11/2017
08:31
Mercurial!
steeplejack
02/11/2017
09:23
Agreed. That scenario is certainly possible. Liked the Lex article . There were a lot of negative comments from the Advisory panel on this possible rival product so we shall see what the FDA actually decide.. Even the final positive vote for just some of that company's doses surprised me. What came through from the speakers/panel was the alarm being created throughout the USA by the opioid crisis. As an aside and referring back to the Indivior product there was a strange reference to one individual's adverse reaction to Bup 6000. That comment under adverse reactions was "death by gunshot!" That adverse reaction was then described as not unusual in that world! To have set that tragic incident down to an adverse reaction seemed bizarre although obviously that person didn't actually complete the trial!
gregmorg
02/11/2017
08:31
CAM2038......Interesting.Yes it seems unlikely Greg that it's going to get the same 'clean bill of health' that RBP-6000 received,in fact Alphaville even suggested that some reckon that a launch of CAM2038 might be delayed for a couple of years giving RBP-6000 a real advantage of building up sales without this competitor cantering alongside.Mind you,given the opioid crisis in the US,I reckon it'll be approved and launch is expected in January next year.
steeplejack
02/11/2017
08:04
We wait on the results to be announced at 11amLEX concluded yesterday ,......."Nor will demand for Suboxone, shown by a 9 per cent jump in Indivior shares. Having retraced almost all of September's fall, they should go higher".
steeplejack
01/11/2017
21:01
Just could be a slight share price easing tomorrow prior to the figures/meeting. Another US company had its inject able product was up before the same FDA Committee tonight. Unlike Indivior with a clean approvals sheet, Camurus/Braeburn got a qualified approval for its CAM2038 but for only some of its proposed doses. The vote was 17 to 3 with the latter 3 indicating NO approval for any of the doses. This product approval process was known about and indeed discussed in a market column of the FT around 11am today. Just not in a position to evaluate the merits of the other product. We will hear what Indivior has to say tomorrow.
gregmorg
01/11/2017
13:18
I understand a couple of brokers have increased their price target- not that that's anything other than a guide to investor sentiment. Both with a share price figure higher than where we are now. Numis has a high figure as follows : " This recommendation for approval significantly de-risks the longer-term investment case, and our target price thus increases to 640p, based on de-risking future cash-flow due to a more normalised discount rate and the assumption of generic film in 2018."
gregmorg
01/11/2017
11:47
Yup, as you say, who knows with this one! Good thing is it is increasingly looking a less dangerous/more secure company. So after the 2nd November we then roll on to that other tester of our investors steel --on the 14th. Will see how that coding scenario has developed . It could be the stock starts to put the days of serious uncertainty behind it. Revenues are looking good and growing very respectably. But what about the veins!~! Thinking of patience(or apathy!) I have been a little puzzled by GSK's share price performance in recent time but am hoping this baptism of fire gears up/fires up the new CEO. OR what! As for my other pharma, IMB, I do wish, Steeplejack, I had more noted your disposal some months back and so questioned my own rationale. Good call. Now I am left waiting for Vaping to kick in! Hopefully this is made less painless by a continued good stream of dividends. Let's see what tomorrow brings on IND . Unfortunately I cannot listen in to the live investors meeting as I have some silly cross country trail commitment. Hopefully I can listen in later in the day.
gregmorg
01/11/2017
08:50
Excellent news.Well done Greg.Extraordinary looking chart.I suppose it's back to litigation for the next plummet or spike,who knows.
steeplejack
01/11/2017
08:35
Brilliant rise in 2 months. 267 to 414. I have to cash in on this now.
sarpanch
Chat Pages: 16  15  14  13  12  11  10  9  8  7  6  5  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20180123 10:13:13